CD24: Difference between revisions
mNo edit summary |
imported>Nat965 m Apply Gen fix(es), Adding link to orphaned article, Wikiproject Orphanage: You can help! using AWB |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | {{Infobox_gene}} | ||
'''Signal transducer CD24''' also known as '''cluster of differentiation 24''' or '''heat stable antigen CD24''' (HSA) is a [[protein]] that in humans is encoded by the ''CD24'' [[gene]].<ref name="pmid7959762">{{cite journal | vauthors = Hough MR, Rosten PM, Sexton TL, Kay R, Humphries RK | title = Mapping of CD24 and homologous sequences to multiple chromosomal loci | journal = Genomics | volume = 22 | issue = 1 | pages = 154–61 |date=July 1994 | pmid = 7959762 | doi = 10.1006/geno.1994.1356 | '''Signal transducer CD24''' also known as '''cluster of differentiation 24''' or '''heat stable antigen CD24''' (HSA) is a [[protein]] that in humans is encoded by the ''CD24'' [[gene]].<ref name="pmid7959762">{{cite journal | vauthors = Hough MR, Rosten PM, Sexton TL, Kay R, Humphries RK | title = Mapping of CD24 and homologous sequences to multiple chromosomal loci | journal = Genomics | volume = 22 | issue = 1 | pages = 154–61 | date = July 1994 | pmid = 7959762 | doi = 10.1006/geno.1994.1356 }}</ref> CD24 is a [[cell adhesion molecule]]. | ||
== Function == | == Function == | ||
CD24 is a [[ | CD24 is a [[sialoglycoprotein]] expressed at the surface of most [[B lymphocyte]]s and differentiating [[neuroblast]]s. It is also expressed on [[neutrophil]]s<ref>{{cite journal | vauthors = Elghetany MT, Patel J | title = Assessment of CD24 expression on bone marrow neutrophilic granulocytes: CD24 is a marker for the myelocytic stage of development | journal = American Journal of Hematology | volume = 71 | issue = 4 | pages = 348–9 | date = December 2002 | pmid = 12447971 | doi = 10.1002/ajh.10176 }}</ref> and neutrophil precursors from the myelocyte stage onwards. The encoded protein is anchored via a glycosyl phosphatidylinositol (GPI) link to the cell surface. The protein also contributes to a wide range of downstream signaling networks and is crucial for neural development.<ref>{{cite journal | vauthors = Gilliam DT, Menon V, Bretz NP, Pruszak J | title = The CD24 surface antigen in neural development and disease | journal = Neurobiology of Disease | volume = 99 | pages = 133–144 | date = March 2017 | pmid = 27993646 | doi = 10.1016/j.nbd.2016.12.011 | url = https://doi.org/10.1016/j.nbd.2016.12.011 }}</ref> Cross-linking of CD24 on the surface of neutrophils induces [[apoptosis]],<ref name = "Parlato_2014">{{cite journal | vauthors = Parlato M, Souza-Fonseca-Guimaraes F, Philippart F, Misset B, Adib-Conquy M, Cavaillon JM | title = CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis | journal = Journal of Immunology | volume = 192 | issue = 5 | pages = 2449–59 | date = March 2014 | pmid = 24501201 | doi = 10.4049/jimmunol.1301055 }}</ref> and this appears to be defective in [[sepsis]].<ref name = "Parlato_2014" /> CD24 gene is found on chromosome 6 (6q21) An alignment of this gene's sequence finds genomic locations with similarity on chromosomes 1p36, 3p26, 15q21.3, 20q11.2 and Yq11.222. Whether transcription, and corresponding translation, occurs at each of these other genomic locations needs to be experimentally determined (source: NCBI). | ||
== References == | == References == | ||
{{Reflist}} | {{Reflist}} | ||
{{clear}} | |||
==Further reading== | == Further reading == | ||
{{refbegin|32em}} | |||
{{refbegin | | * {{cite journal | vauthors = Li D, Zheng L, Jin L, Zhou Y, Li H, Fu J, Shi M, Du P, Wang L, Wu H, Chen GY, Zheng P, Liu Y, Wang FS, Wang S | title = CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection | journal = Hepatology | volume = 50 | issue = 3 | pages = 735–42 | date = September 2009 | pmid = 19610054 | doi = 10.1002/hep.23047 }} | ||
*{{cite journal | * {{cite journal | vauthors = Piotrowski P, Lianeri M, Wudarski M, Łacki JK, Jagodziński PP | title = CD24 Ala57Val gene polymorphism and the risk of systemic lupus erythematosus | journal = Tissue Antigens | volume = 75 | issue = 6 | pages = 696–700 | date = June 2010 | pmid = 20230526 | doi = 10.1111/j.1399-0039.2010.01447.x }} | ||
*{{cite journal | * {{cite journal | vauthors = Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C | title = The CD44+/CD24- phenotype is enriched in basal-like breast tumors | journal = Breast Cancer Research | volume = 10 | issue = 3 | pages = R53 | year = 2008 | pmid = 18559090 | pmc = 2481503 | doi = 10.1186/bcr2108 }} | ||
*{{cite journal | * {{cite journal | vauthors = Nagy B, Szendroi A, Romics I | title = Overexpression of CD24, c-myc and phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy | journal = Pathology Oncology Research | volume = 15 | issue = 2 | pages = 279–83 | date = June 2009 | pmid = 18752058 | doi = 10.1007/s12253-008-9077-1 }} | ||
*{{cite journal | * {{cite journal | vauthors = Kim KH, Choi JS, Kim JM, Choi YL, Shin YK, Lee HC, Seong IO, Kim BK, Chae SW, Kim SH | title = Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium | journal = Histology and Histopathology | volume = 24 | issue = 3 | pages = 309–16 | date = March 2009 | pmid = 19130400 | doi = 10.14670/HH-24.309 }} | ||
*{{cite journal | * {{cite journal | vauthors = Buess M, Rajski M, Vogel-Durrer BM, Herrmann R, Rochlitz C | title = Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer | journal = Neoplasia | volume = 11 | issue = 10 | pages = 987–1002 | date = October 2009 | pmid = 19794958 | pmc = 2745665 | doi = 10.1593/neo.09670 }} | ||
*{{cite journal | * {{cite journal | vauthors = Pruszak J, Ludwig W, Blak A, Alavian K, Isacson O | title = CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells | journal = Stem Cells | volume = 27 | issue = 12 | pages = 2928–40 | date = December 2009 | pmid = 19725119 | pmc = 3322476 | doi = 10.1002/stem.211 }} | ||
*{{cite journal | * {{cite journal | vauthors = Liu Y, Chen GY, Zheng P | title = CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns | journal = Trends in Immunology | volume = 30 | issue = 12 | pages = 557–61 | date = December 2009 | pmid = 19786366 | pmc = 2788100 | doi = 10.1016/j.it.2009.09.006 }} | ||
*{{cite journal | * {{cite journal | vauthors = Vesuna F, Lisok A, Kimble B, Raman V | title = Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression | journal = Neoplasia | volume = 11 | issue = 12 | pages = 1318–28 | date = December 2009 | pmid = 20019840 | pmc = 2794513 | doi = 10.1593/neo.91084 }} | ||
*{{cite journal | * {{cite journal | vauthors = Sagiv E, Arber N | title = The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy | journal = [[Expert Review of Gastroenterology & Hepatology]] | volume = 2 | issue = 1 | pages = 125–33 | date = February 2008 | pmid = 19072375 | doi = 10.1586/17474124.2.1.125 }} | ||
*{{cite journal | * {{cite journal | vauthors = Bauerschmitz GJ, Ranki T, Kangasniemi L, Ribacka C, Eriksson M, Porten M, Herrmann I, Ristimäki A, Virkkunen P, Tarkkanen M, Hakkarainen T, Kanerva A, Rein D, Pesonen S, Hemminki A | title = Tissue-specific promoters active in CD44+CD24-/low breast cancer cells | journal = Cancer Research | volume = 68 | issue = 14 | pages = 5533–9 | date = July 2008 | pmid = 18632604 | doi = 10.1158/0008-5472.CAN-07-5288 }} | ||
*{{cite journal | * {{cite journal | vauthors = Carl JW, Liu JQ, Joshi PS, El-Omrani HY, Yin L, Zheng X, Whitacre CC, Liu Y, Bai XF | title = Autoreactive T cells escape clonal deletion in the thymus by a CD24-dependent pathway | journal = Journal of Immunology | volume = 181 | issue = 1 | pages = 320–8 | date = July 2008 | pmid = 18566397 | doi = 10.4049/jimmunol.181.1.320 }} | ||
*{{cite journal | * {{cite journal | vauthors = Baumhoer D, Riener MO, Zlobec I, Tornillo L, Vogetseder A, Kristiansen G, Dietmaier W, Hartmann A, Wuensch PH, Sessa F, Ruemmele P, Terracciano LM | title = Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater | journal = Modern Pathology | volume = 22 | issue = 2 | pages = 306–13 | date = February 2009 | pmid = 19043399 | doi = 10.1038/modpathol.2008.192 }} | ||
*{{cite journal | * {{cite journal | vauthors = Wang W, Wang X, Peng L, Deng Q, Liang Y, Qing H, Jiang B | title = CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation | journal = Cancer Science | volume = 101 | issue = 1 | pages = 112–9 | date = January 2010 | pmid = 19860845 | doi = 10.1111/j.1349-7006.2009.01370.x }} | ||
*{{cite journal | * {{cite journal | vauthors = Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, Kuwano H | title = CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma | journal = Annals of Surgical Oncology | volume = 16 | issue = 2 | pages = 506–14 | date = February 2009 | pmid = 19050962 | doi = 10.1245/s10434-008-0252-0 }} | ||
*{{cite journal | * {{cite journal | vauthors = Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J | title = CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery | journal = Clinical Cancer Research | volume = 15 | issue = 17 | pages = 5518–27 | date = September 2009 | pmid = 19706825 | doi = 10.1158/1078-0432.CCR-09-0151 }} | ||
*{{cite journal | * {{cite journal | vauthors = Lee JH, Kim SH, Lee ES, Kim YS | title = CD24 overexpression in cancer development and progression: a meta-analysis | journal = Oncology Reports | volume = 22 | issue = 5 | pages = 1149–56 | date = November 2009 | pmid = 19787233 | doi = 10.3892/or_00000548 }} | ||
*{{cite journal | * {{cite journal | vauthors = Gekara NO, Weiss S | title = Lipid rafts clustering and signalling by listeriolysin O | journal = Biochemical Society Transactions | volume = 32 | issue = Pt 5 | pages = 712–4 | date = November 2004 | pmid = 15493995 | doi = 10.1042/BST0320712 }} | ||
*{{cite journal | * {{cite journal | vauthors = Athanassiadou P, Grapsa D, Gonidi M, Athanassiadou AM, Tsipis A, Patsouris E | title = CD24 expression has a prognostic impact in breast carcinoma | journal = Pathology, Research and Practice | volume = 205 | issue = 8 | pages = 524–33 | year = 2009 | pmid = 19243896 | doi = 10.1016/j.prp.2009.01.008 }} | ||
*{{cite journal | * {{cite journal | vauthors = Ronaghi M, Vallian S, Etemadifar M | title = CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population | journal = Psychiatry Research | volume = 170 | issue = 2-3 | pages = 271–2 | date = December 2009 | pmid = 19896210 | doi = 10.1016/j.psychres.2009.01.002 }} | ||
*{{cite journal | |||
{{refend}} | {{refend}} | ||
==External links== | == External links == | ||
* {{MeshName|CD24+Antigen}} | * {{MeshName|CD24+Antigen}} | ||
* [http://www.ebioscience.com/ebioscience/whatsnew/mousecdchart.htm Mouse CD Antigen Chart] | * [http://www.ebioscience.com/ebioscience/whatsnew/mousecdchart.htm Mouse CD Antigen Chart] |
Latest revision as of 00:40, 15 June 2018
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Signal transducer CD24 also known as cluster of differentiation 24 or heat stable antigen CD24 (HSA) is a protein that in humans is encoded by the CD24 gene.[1] CD24 is a cell adhesion molecule.
Function
CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils[2] and neutrophil precursors from the myelocyte stage onwards. The encoded protein is anchored via a glycosyl phosphatidylinositol (GPI) link to the cell surface. The protein also contributes to a wide range of downstream signaling networks and is crucial for neural development.[3] Cross-linking of CD24 on the surface of neutrophils induces apoptosis,[4] and this appears to be defective in sepsis.[4] CD24 gene is found on chromosome 6 (6q21) An alignment of this gene's sequence finds genomic locations with similarity on chromosomes 1p36, 3p26, 15q21.3, 20q11.2 and Yq11.222. Whether transcription, and corresponding translation, occurs at each of these other genomic locations needs to be experimentally determined (source: NCBI).
References
- ↑ Hough MR, Rosten PM, Sexton TL, Kay R, Humphries RK (July 1994). "Mapping of CD24 and homologous sequences to multiple chromosomal loci". Genomics. 22 (1): 154–61. doi:10.1006/geno.1994.1356. PMID 7959762.
- ↑ Elghetany MT, Patel J (December 2002). "Assessment of CD24 expression on bone marrow neutrophilic granulocytes: CD24 is a marker for the myelocytic stage of development". American Journal of Hematology. 71 (4): 348–9. doi:10.1002/ajh.10176. PMID 12447971.
- ↑ Gilliam DT, Menon V, Bretz NP, Pruszak J (March 2017). "The CD24 surface antigen in neural development and disease". Neurobiology of Disease. 99: 133–144. doi:10.1016/j.nbd.2016.12.011. PMID 27993646.
- ↑ 4.0 4.1 Parlato M, Souza-Fonseca-Guimaraes F, Philippart F, Misset B, Adib-Conquy M, Cavaillon JM (March 2014). "CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis". Journal of Immunology. 192 (5): 2449–59. doi:10.4049/jimmunol.1301055. PMID 24501201.
Further reading
- Li D, Zheng L, Jin L, Zhou Y, Li H, Fu J, Shi M, Du P, Wang L, Wu H, Chen GY, Zheng P, Liu Y, Wang FS, Wang S (September 2009). "CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection". Hepatology. 50 (3): 735–42. doi:10.1002/hep.23047. PMID 19610054.
- Piotrowski P, Lianeri M, Wudarski M, Łacki JK, Jagodziński PP (June 2010). "CD24 Ala57Val gene polymorphism and the risk of systemic lupus erythematosus". Tissue Antigens. 75 (6): 696–700. doi:10.1111/j.1399-0039.2010.01447.x. PMID 20230526.
- Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C (2008). "The CD44+/CD24- phenotype is enriched in basal-like breast tumors". Breast Cancer Research. 10 (3): R53. doi:10.1186/bcr2108. PMC 2481503. PMID 18559090.
- Nagy B, Szendroi A, Romics I (June 2009). "Overexpression of CD24, c-myc and phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy". Pathology Oncology Research. 15 (2): 279–83. doi:10.1007/s12253-008-9077-1. PMID 18752058.
- Kim KH, Choi JS, Kim JM, Choi YL, Shin YK, Lee HC, Seong IO, Kim BK, Chae SW, Kim SH (March 2009). "Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium". Histology and Histopathology. 24 (3): 309–16. doi:10.14670/HH-24.309. PMID 19130400.
- Buess M, Rajski M, Vogel-Durrer BM, Herrmann R, Rochlitz C (October 2009). "Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer". Neoplasia. 11 (10): 987–1002. doi:10.1593/neo.09670. PMC 2745665. PMID 19794958.
- Pruszak J, Ludwig W, Blak A, Alavian K, Isacson O (December 2009). "CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells". Stem Cells. 27 (12): 2928–40. doi:10.1002/stem.211. PMC 3322476. PMID 19725119.
- Liu Y, Chen GY, Zheng P (December 2009). "CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns". Trends in Immunology. 30 (12): 557–61. doi:10.1016/j.it.2009.09.006. PMC 2788100. PMID 19786366.
- Vesuna F, Lisok A, Kimble B, Raman V (December 2009). "Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression". Neoplasia. 11 (12): 1318–28. doi:10.1593/neo.91084. PMC 2794513. PMID 20019840.
- Sagiv E, Arber N (February 2008). "The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy". Expert Review of Gastroenterology & Hepatology. 2 (1): 125–33. doi:10.1586/17474124.2.1.125. PMID 19072375.
- Bauerschmitz GJ, Ranki T, Kangasniemi L, Ribacka C, Eriksson M, Porten M, Herrmann I, Ristimäki A, Virkkunen P, Tarkkanen M, Hakkarainen T, Kanerva A, Rein D, Pesonen S, Hemminki A (July 2008). "Tissue-specific promoters active in CD44+CD24-/low breast cancer cells". Cancer Research. 68 (14): 5533–9. doi:10.1158/0008-5472.CAN-07-5288. PMID 18632604.
- Carl JW, Liu JQ, Joshi PS, El-Omrani HY, Yin L, Zheng X, Whitacre CC, Liu Y, Bai XF (July 2008). "Autoreactive T cells escape clonal deletion in the thymus by a CD24-dependent pathway". Journal of Immunology. 181 (1): 320–8. doi:10.4049/jimmunol.181.1.320. PMID 18566397.
- Baumhoer D, Riener MO, Zlobec I, Tornillo L, Vogetseder A, Kristiansen G, Dietmaier W, Hartmann A, Wuensch PH, Sessa F, Ruemmele P, Terracciano LM (February 2009). "Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater". Modern Pathology. 22 (2): 306–13. doi:10.1038/modpathol.2008.192. PMID 19043399.
- Wang W, Wang X, Peng L, Deng Q, Liang Y, Qing H, Jiang B (January 2010). "CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation". Cancer Science. 101 (1): 112–9. doi:10.1111/j.1349-7006.2009.01370.x. PMID 19860845.
- Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, Kuwano H (February 2009). "CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma". Annals of Surgical Oncology. 16 (2): 506–14. doi:10.1245/s10434-008-0252-0. PMID 19050962.
- Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J (September 2009). "CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery". Clinical Cancer Research. 15 (17): 5518–27. doi:10.1158/1078-0432.CCR-09-0151. PMID 19706825.
- Lee JH, Kim SH, Lee ES, Kim YS (November 2009). "CD24 overexpression in cancer development and progression: a meta-analysis". Oncology Reports. 22 (5): 1149–56. doi:10.3892/or_00000548. PMID 19787233.
- Gekara NO, Weiss S (November 2004). "Lipid rafts clustering and signalling by listeriolysin O". Biochemical Society Transactions. 32 (Pt 5): 712–4. doi:10.1042/BST0320712. PMID 15493995.
- Athanassiadou P, Grapsa D, Gonidi M, Athanassiadou AM, Tsipis A, Patsouris E (2009). "CD24 expression has a prognostic impact in breast carcinoma". Pathology, Research and Practice. 205 (8): 524–33. doi:10.1016/j.prp.2009.01.008. PMID 19243896.
- Ronaghi M, Vallian S, Etemadifar M (December 2009). "CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population". Psychiatry Research. 170 (2–3): 271–2. doi:10.1016/j.psychres.2009.01.002. PMID 19896210.
External links
- CD24+Antigen at the US National Library of Medicine Medical Subject Headings (MeSH)
- Mouse CD Antigen Chart
- Human CD Antigen Chart
- www.copewithcytokines.de: description of CD24 expression
- CD24 human gene location in the UCSC Genome Browser.
- CD24 human gene details in the UCSC Genome Browser.
Stub icon | This membrane protein–related article is a stub. You can help Wikipedia by expanding it. |